To determine the tolerable upper intake level of nicotinic acid in humans, we investigated the e#ects of excess nicotinic acid administration on body weight gain, food intake, and urinary excretion of water-soluble vitamins and the metabolism of tryptophan in weaning rats. The weaning rats were freely fed a niacinῌfree 20 casein diet (control diet) or the same diet with 0.1, 0.3 or 0.5 nicotinic acid for 23 days. The excess nicotinic acid intake did not a#ect body weight gain, food intake, serotonin contents in the brain, stomach and small intestine, or the urinary excretions of water-soluble vitamins. Although excess nicotinic acid did not a#ect the upper part of the tryptophanῌnicotinamide pathway, 0.5 nicotinic acid diet increased the urinary excretion of quinolinic acid. The diet containing more than 0.3 nicotinic acid also increased the urinary excretion of nicotinic acid, which is usually below the limit of detection. As determined from the results of body weight gain and food intake as indices for apparent adverse e#ects, the no-observed-adverse-e#ect-level (NOAEL) for nicotinic acid was 0.5 in diet, corresponding to 450 mg/kg body weight/day. As judged from in increase of urinary quinolinic acid and nicotinic acid as indices of metabolic change, NOAEL was 0.1 in diet, corresponding to 90 mg/kg body weight/day, and the lowest-observed-adverse-e#ect-level (LOAEL) was 0.3 in diet, corresponding to 270 mg/kg body weight/day.
Each value is expressed as the meanῒSEM (nΐ5). Each value is expressed as the meanῑSEM (nῒ5). ῍pΐ0.05 versus control determined by ANOVA followed by TukeyῌKramer multiple comparison test. 
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